Prenetics Acquires ACT Genomics, Creating a Leader in Compre

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Grail (acquired by Illumina), Exact Sciences, Guardant Health and more Expects ACT to contribute US$25-30 million...

Related Keywords

Taiwan , Japan , Tokyo , Science Park , Singapore General , Singapore , Hong Kong , United Kingdom , China , Taipei , T Ai Pei , South Africa , Kyoto , London , City Of , India , Thailand , University Of Hong Kong , Hong Kong General , National University Of Singapore , Bangkok , Krung Thep Mahanakhon , Danny Yeung , Tony Mok , Albert Wong , Hua Chien Chen , Technology Parks Corporation , China Limited Nasdaq , Guardant Health , University Of Oxford , Kyoto University , Chinese University Of Hong Kong , Nasdaq , Genomics Holdings Company Limited , Astrazeneca , Prnewswire Prenetics Global Limited , Consumer Health , Foundation One , Exact Sciences , Global Limited , Holdings Company Limited , Danny Yeung Co Founder , Chief Executive Officer , Prenetics Scientific Advisory Board , Chair Professor , Clinical Oncology , Chinese University , Hong Kong Science , Hong Kong Science Park , Comprehensive Cancer Genetics , Cancer Diagnostics , National University , Next Generation Sequencing , Clinical Care , Cancer Genomics ,